The burden of major adverse cardiac events and antiplatelet prevention in patients with coronary or peripheral arterial disease

ConclusionDespite gaps in the literature, this assessment showed that MACE's risk is substantial among CAD or PAD patients and that the use of preventive therapies is suboptimal. Development of additional preventive therapies for these patients is warranted.This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2F1755-5922.12169

Source: Cardiovascular Therapeutics - December 1, 2015 Category: Cardiology Authors: Hanane Khoury, Louis Lavoie, Sharon Welner, Kerstin Folkerts Tags: Unsolicited Review Source Type: research